Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies

Cancer immunology research

Volumn 2, Issue 2, 2014, Pages 112-120

  Beatty, Gregory L ^a   Haas, Andrew R ^a   Maus, Marcela V ^a   Torigian, Drew A ^a   Soulen, Michael C ^a   Plesa, Gabriela ^a   Chew, Anne ^a   Zhao, Yangbing ^a   Levine, Bruce L ^a   Albelda, Steven M ^a   Kalos, Michael ^a   June, Carl H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MESOTHELIN; MESSENGER RNA;

ADOPTIVE IMMUNOTHERAPY; ADVERSE EFFECTS; AGED; CHIMERA; CLINICAL TRIAL; ELECTROPORATION; FEASIBILITY STUDY; GENETIC ENGINEERING; GENETICS; HUMAN; IMMUNOLOGY; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PANCREATIC NEOPLASMS; PHASE 1 CLINICAL TRIAL; PLEURAL NEOPLASMS; PROCEDURES; T LYMPHOCYTE SUBPOPULATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHIMERISM; ELECTROPORATION; FEASIBILITY STUDIES; GENETIC ENGINEERING; GPI-LINKED PROTEINS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PANCREATIC NEOPLASMS; PLEURAL NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 84996572349     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0170     Document Type: Article

References (0)